Skip to content

In the BioHarmony Drug Report Database

Droxidopa

Northera (droxidopa) is a small molecule pharmaceutical. Droxidopa was first approved as Northera on 2014-02-18. It is used to treat orthostatic hypotension in the USA. It is known to target muscarinic acetylcholine receptor M1.
Trade Name Northera
Common Name Droxidopa
Indication orthostatic hypotension
Drug Class Dopamine receptor agonists
Droxidopa
Get full access now